Zdrowie i gospodarka · 07/10/2008

FDA Publishes Draft Guidance on New Contrast Imaging Indication Considerations for Medical Devices and Approved Drug and Biological Products

The Food and Drug Administration (FDA) has released a draft guidance document to help developers of medical imaging devices and imaging drug/biological products create new contrast indications for imaging devices, with the goal of promoting timely and effective review and regulation of these products.